BACKGROUND: The implementation of disease-specific research or service programs may have an ancillary beneficial or harmful impact on routine clinical services. METHODS: We reviewed the records of 5801 first visits to 22 antenatal clinics from 1997 to 2004 in Lusaka, Zambia and examined documented syphilis rapid plasma reagin (RPR) screening and syphilis treatment before and after implementation of research and/or service programs in prevention of mother-to-child (PMTCT) HIV transmission. FINDINGS: Compared with before PMTCT program implementation, the prevalence odds ratios (PORs) and 95% confidence intervals (CIs) for documented RPR screening were 0.9 (0.7 to 1.1) after implementation of research, 0.7 (0.6 to 0.8) after service, and 2.5 (2.1 to 3.0) after research and service programs. CONCLUSIONS: Documented RPR screening was improved after implementation of PMTCT research and service were operating simultaneously and not with research or service alone. Health policy makers and researchers should plan explicitly for how the targeted HIV programs, service, and/or research can have a broader primary care impact.
BACKGROUND: The implementation of disease-specific research or service programs may have an ancillary beneficial or harmful impact on routine clinical services. METHODS: We reviewed the records of 5801 first visits to 22 antenatal clinics from 1997 to 2004 in Lusaka, Zambia and examined documented syphilis rapid plasma reagin (RPR) screening and syphilis treatment before and after implementation of research and/or service programs in prevention of mother-to-child (PMTCT) HIV transmission. FINDINGS: Compared with before PMTCT program implementation, the prevalence odds ratios (PORs) and 95% confidence intervals (CIs) for documented RPR screening were 0.9 (0.7 to 1.1) after implementation of research, 0.7 (0.6 to 0.8) after service, and 2.5 (2.1 to 3.0) after research and service programs. CONCLUSIONS: Documented RPR screening was improved after implementation of PMTCT research and service were operating simultaneously and not with research or service alone. Health policy makers and researchers should plan explicitly for how the targeted HIV programs, service, and/or research can have a broader primary care impact.
Authors: Benjamin H Chi; Moses Sinkala; Elizabeth M Stringer; Yvette McFarlane; Catherine Ng'uni; Elizabeth Myzece; Robert L Goldenberg; Jeffrey S A Stringer Journal: J Acquir Immune Defic Syndr Date: 2005-11-01 Impact factor: 3.731
Authors: Thomas K Welty; Marc Bulterys; Edith R Welty; Pius M Tih; George Ndikintum; Godlove Nkuoh; Joseph Nkfusai; Janet Kayita; John N Nkengasong; Catherine M Wilfert Journal: J Acquir Immune Defic Syndr Date: 2005-12-01 Impact factor: 3.731
Authors: Elizabeth M Stringer; Moses Sinkala; Jeffrey S Stringer; Elizabeth Mzyece; Ida Makuka; Robert L Goldenberg; Pascal Kwape; Martha Chilufya; Sten H Vermund Journal: AIDS Date: 2003-06-13 Impact factor: 4.177
Authors: Samuel Abimerech Luboga; Bert Stover; Travis W Lim; Frederick Makumbi; Noah Kiwanuka; Flavia Lubega; Assay Ndizihiwe; Eddie Mukooyo; Erin K Hurley; Nagesh Borse; Angela Wood; James Bernhardt; Nathaniel Lohman; Lianne Sheppard; Scott Barnhart; Amy Hagopian Journal: Health Policy Plan Date: 2016-03-27 Impact factor: 3.344
Authors: Ruairí Brugha; Joseph Simbaya; Aisling Walsh; Patrick Dicker; Phillimon Ndubani Journal: BMC Public Health Date: 2010-09-08 Impact factor: 3.295